Abstract
The present study was designed to investigate possible differing mechanisms of tolerance to opioids of various efficacies. We, as well as others, have shown that the administration of highly selective inhibitors of protein kinase C (PKC) and A (PKA) completely reversed morphine antinociceptive tolerance in mice. We now have investigated whether these inhibitors reverse tolerance to other opioids of low and high efficacy. An 8‐hr model of acute tolerance was used in which the test opioid was administered repeatedly at a dose which yielded maximum antinociception in naïve mice. Animals were then challenged with increasing doses of the test opioid with and without the PKC and PKA inhibitors to construct a dose response curve. The 8‐hr tolerance to the low‐efficacy μ‐agonist meperidine and the moderate‐efficacy μ‐agonists, morphine and fentanyl was fully reversed by the PKC inhibitors Bisindolymaleimide I, and Gö6976 as well as the PKA inhibitor PKI 14‐22. However tolerance to DAMGO, a highly efficacious μ‐opioid agonist, was not reversed by injection of either the PKC inhibitor Gö6976 or the PKA inhibitor PKI 14‐22 suggesting that μ‐opioid receptor desensitization induced by high‐efficacy μ‐agonists is independent of PKC or PKA activation. It can be concluded that the mechanisms underlying μ‐opioid receptor desensitization may be determined by the agonist activating the receptor. Supported by DA01647 and DA020836.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.